Metabolomic Plasma Profile of Chronic Obstructive Pulmonary Disease Patients
Authors:
- Carme CasadevallCCCarme Casadevall
- Bella AgranovichBABella Agranovich
- Cesar Jesse Enríquez-RodríguezCesar Jesse Enríquez-Rodríguez
- Rosa FanerRFRosa Faner
- Sergi Pascual-GuàrdiaSPSergi Pascual-Guàrdia
- Ady Castro-AcostaACAdy Castro-Acosta
- Ramon Camps-UbachRCRamon Camps-Ubach
- Judith Garcia-AymerichJGJudith Garcia-Aymerich
- Esther BarreiroEBEsther Barreiro
- Eduard MonsóEMEduard Monsó
- Luis SeijoLSLuis Seijo
- Juan José Soler-CataluñaJSJuan José Soler-Cataluña
Open Access
- 9 May 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (10) , 4526
Abstract
The analysis of blood metabolites may help identify individuals at risk of having COPD and offer insights into its underlying pathophysiology. This study aimed to identify COPD-related metabolic alterations and generate a biological signature potentially useful for screening purposes. Plasma metabolomic profiles from 91 COPD patients and 91 controls were obtained using complementary semi-targeted and untargeted LC-MS approaches. Univariate analysis identified metabolites with significant differences between groups, and enrichment analysis highlighted the most affected metabolic pathways. Multivariate analysis, including ROC curve assessment and machine learning algorithms, was applied to assess the discriminatory capacity of selected metabolites. After adjustment for major potential confounders, 56 metabolites showed significant differences between COPD patients and controls. The enrichment analysis revealed that COPD-associated metabolic alterations primarily involved lipid metabolism (especially fatty acids and acylcarnitines), followed by amino acid pathways and xenobiotics. A panel of 10 metabolites, mostly related to lipid metabolism, demonstrated high discriminatory performance for COPD (ROC-AUC: 0.916; 90.1% sensitivity and 89% specificity). These findings may contribute to improving screening strategies and a better understanding of COPD-related metabolic changes. However, our findings remain exploratory and should be interpreted with caution, needing further validation and mechanistic studies.Keywords
Funding Information
- Spanish Ministerio de Economía y Competitividad and the European Union (SAF2014-54371, 2015, 2016 and 2019, 2014, 2020, Unrestricted Grant 2015-19, PI17/00369, PI18/01008, PI21/00785 and M-BAE BA22/00009, FI22/00003, M-AES MV23/00012)
- Sociedad Española de Neumología y Cirugía Torácica (SAF2014-54371, 2015, 2016 and 2019, 2014, 2020, Unrestricted Grant 2015-19, PI17/00369, PI18/01008, PI21/00785 and M-BAE BA22/00009, FI22/00003, M-AES MV23/00012)
- FUCAP (SAF2014-54371, 2015, 2016 and 2019, 2014, 2020, Unrestricted Grant 2015-19, PI17/00369, PI18/01008, PI21/00785 and M-BAE BA22/00009, FI22/00003, M-AES MV23/00012)
- SOCAP (SAF2014-54371, 2015, 2016 and 2019, 2014, 2020, Unrestricted Grant 2015-19, PI17/00369, PI18/01008, PI21/00785 and M-BAE BA22/00009, FI22/00003, M-AES MV23/00012)
- Menarini Spain (SAF2014-54371, 2015, 2016 and 2019, 2014, 2020, Unrestricted Grant 2015-19, PI17/00369, PI18/01008, PI21/00785 and M-BAE BA22/00009, FI22/00003, M-AES MV23/00012)
- Instituto de Salud Carlos III (ISCIII) and European Union (SAF2014-54371, 2015, 2016 and 2019, 2014, 2020, Unrestricted Grant 2015-19, PI17/00369, PI18/01008, PI21/00785 and M-BAE BA22/00009, FI22/00003, M-AES MV23/00012)
- predoctoral grant PFIS (SAF2014-54371, 2015, 2016 and 2019, 2014, 2020, Unrestricted Grant 2015-19, PI17/00369, PI18/01008, PI21/00785 and M-BAE BA22/00009, FI22/00003, M-AES MV23/00012)
- Mobility of Research Personnel Grant (SAF2014-54371, 2015, 2016 and 2019, 2014, 2020, Unrestricted Grant 2015-19, PI17/00369, PI18/01008, PI21/00785 and M-BAE BA22/00009, FI22/00003, M-AES MV23/00012)
This publication has 90 references indexed in Scilit:
- Imbalance of gut microbiota is involved in the development of chronic obstructive pulmonary disease: A reviewBiomedicine & Pharmacotherapy, 2023
- Metabolomics in COPDArchivos de Bronconeumología, 2023
- Lipidomic analysis reveals the effect of passive smoking on facial skin surface lipid in femalesChemistry and Physics of Lipids, 2022
- Can we increase efficiency of CT lung cancer screening by combining with CVD and COPD screening? Results of an early economic evaluationEuropean Radiology, 2022
- Prevalence and Determinants of COPD in Spain: EPISCAN IIArchivos de Bronconeumología, 2021
- Metabolomic signatures of asthma-COPD overlap (ACO) are different from asthma and COPDMetabolomics, 2019
- EARLY COPD: determinantes de la aparición y progresión de la enfermedad pulmonar obstructiva crónica en adultos jóvenes. Protocolo de un estudio caso-control con seguimientoArchivos de Bronconeumología, 2019
- Proyecto de biomarcadores y perfiles clínicos personalizados en la enfermedad pulmonar obstructiva crónica (proyecto BIOMEPOC)Archivos de Bronconeumología, 2019
- Analysis of Cell Metabolism Using LC-MS and Isotope Tracers2015
- Association between tobacco smoke exposure and levels of C-reactive protein in the Oslo II StudyEuropean Journal of Epidemiology, 2007